Novel Norovirus GII.4 Variant, Shanghai, China, 2012

Zhen Shen(Third People's Hospital of Yunnan Province), Jun Zhang(Sir Run Run Shaw Hospital), Zhenghong Yuan(Shanghai Medical College of Fudan University), Yang Li(Tang Hospital), Fangxing Qian(Shanghai Changning Maternity and Infant Health Hospital), Yunwen Hu(Southern University of Science and Technology)
Emerging infectious diseases
June 27, 2013
10.3201/eid1908.130026
Cited by 15

Related Papers

Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization
|Proceedings of the National Academy of Sciences|2009|864
Etiological and epidemiological features of acute respiratory infections in China
|Nature Communications|2021|530
Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids
|Protein & Cell|2020|397
Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance
|The Lancet|2013|359